OVARIAN CANCER PREVENTION AND EARLY DETECTION
For years Ovarian Cancer has been appropriately referred to as the ‘silent killer’. This is because the disease is common (1 in 55 women), serious and silent in the early stages. In the United States alone we see 21,300 new cases and 14,200 deaths annually. Despite major surgery, major chemotherapy and occasional radiation resulting in high morbidity, note the high overall death to incidence rate. Less that
15% are found early (Stage I and early Stage II) with routine annual exams or by waiting for symptoms to occur. The GOOD NEWS is that early stage ovarian cancer has a 92+% 5-year survival rate when found localized in the early stages and treated with simple surgery alone (no chemotherapy or radiation required).
So how do we find Ovarian Cancer early?
By screening with trans-vaginal ultrasound (sonogram) or TVS. This is a simple, safe, non-invasive, effective, painless and very practical way to detect ovarian cancer and other forms of pelvic cancer including occult endo-cervical, endometrial, fallopian tube, ovarian and peritoneal. Ca-125 and/or other blood testing biomarkers are not effective nor recommended for first line screening.
Those tests may be useful to better characterize the potential for malignancy in the presence of an ovarian or fallopian tube abnormality. We offer evidence-based, state-of-the-art, high-definition TVS screening for women’s pelvic cancers utilizing the Yale University, University of Kentucky and England (United Kingdom)
protocols. This technique is very effective, comfortable and does NOT require a full bladder. With over 34 years of experience in interpretation and clinical correlation, false positive results and the potential for unnecessary surgery for benign conditions are not a problem in our practice.
To reduce the mortality and morbidity of women’s cancers through education, prevention, and early detection.
Candidates for Evaluation
Any woman 25 to 90 years of age with a life expectancy of 5 or more years with the presence of one or both ovaries.